Zylox-Tonbridge Medical Technology Co., Ltd. Class H (HK:2190)
:2190
Want to see HK:2190 full AI Analyst Report?
Total Valuation
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has a market cap or net worth of HK$7.19B. The enterprise value is HK$5.12B.
Market CapHK$7.19B
Enterprise ValueHK$5.12B
Share Statistics
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has 336,350,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding336,350,740
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.94%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)5.94%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.21M
Profits Per Employee272.05K
Employee Count875
Asset Turnover0.30
Inventory Turnover1.58
Valuation Ratios
The current PE Ratio of Zylox-Tonbridge Medical Technology Co., Ltd. Class H is 27.5. Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s PEG ratio is 0.19.
PE Ratio27.5
PS Ratio6.35
PB Ratio2.08
Price to Fair Value2.08
Price to FCF24.98
Price to Operating Cash Flow25.14
PEG Ratio0.19
Income Statement
In the last 12 months, Zylox-Tonbridge Medical Technology Co., Ltd. Class H had revenue of 1.06B and earned 244.37M in profits. Earnings per share was 0.76.
Revenue1.06B
Gross Profit762.92M
Operating Income196.64M
Pretax Income230.61M
Net Income244.37M
EBITDA231.92M
Earnings Per Share (EPS)0.76
Cash Flow
In the last 12 months, operating cash flow was 230.60M and capital expenditures -59.28M, giving a free cash flow of 171.33M billion.
Operating Cash Flow230.60M
Free Cash Flow171.33M
Free Cash Flow per Share0.51
Dividends & Yields
Zylox-Tonbridge Medical Technology Co., Ltd. Class H pays an annual dividend of HK$0.109, resulting in a dividend yield of 0.48%
Dividend Per ShareHK$0.109
Dividend Yield0.48%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change7.25%
50-Day Moving Average22.68
200-Day Moving Average23.69
Relative Strength Index (RSI)31.48
Average Volume (3m)743.29K
Important Dates
Zylox-Tonbridge Medical Technology Co., Ltd. Class H upcoming earnings date is Aug 31, 2026, TBA (Confirmed).
Last Earnings DateMar 17, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date―
Financial Position
Zylox-Tonbridge Medical Technology Co., Ltd. Class H as a current ratio of 5.98, with Debt / Equity ratio of 1.97%
Current Ratio5.98
Quick Ratio5.41
Debt to Market Cap<0.01
Net Debt to EBITDA-2.23
Interest Coverage Ratio197.32
Taxes
In the past 12 months, Zylox-Tonbridge Medical Technology Co., Ltd. Class H has paid -7.43M in taxes.
Income Tax-7.43M
Effective Tax Rate-0.03
Enterprise Valuation
Zylox-Tonbridge Medical Technology Co., Ltd. Class H EV to EBITDA ratio is 26.72, with an EV/FCF ratio of 23.06.
EV to Sales5.86
EV to EBITDA26.72
EV to Free Cash Flow23.06
EV to Operating Cash Flow16.44
Balance Sheet
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has HK$1.73B in cash and marketable securities with HK$63.67M in debt, giving a net cash position of HK$1.67B billion.
Cash & Marketable SecuritiesHK$1.73B
Total DebtHK$63.67M
Net CashHK$1.67B
Net Cash Per ShareHK$4.96
Tangible Book Value Per ShareHK$9.86
Margins
Gross margin is 72.14%, with operating margin of 18.59%, and net profit margin of 23.11%.
Gross Margin72.14%
Operating Margin18.59%
Pretax Margin21.81%
Net Profit Margin23.11%
EBITDA Margin21.93%
EBIT Margin18.80%
Analyst Forecast
The average price target for Zylox-Tonbridge Medical Technology Co., Ltd. Class H is HK$30.22, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$30.22
Price Target Upside22.63% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast35.28%
EPS Growth Forecast146.71%